Sawicki Mark W 4
4 · Cryoport, Inc. · Filed Sep 13, 2023
Insider Transaction Report
Form 4
Cryoport, Inc.CYRX
Sawicki Mark W
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2023-09-12$12.79/sh+1,000$12,790→ 73,125 total - Exercise/Conversion
Stock Option (right to buy)
2023-09-12−1,000→ 89,000 totalExercise: $12.79Exp: 2029-04-01→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]No Common Stock was sold by the reporting person in connection with the transactions disclosed on this Form 4.
- [F2]Options vested as part of an option that began vesting on the 1st of each month for forty-eight months beginning May 1, 2019.